Human Molecular Genetics, 2001, Vol. 10, No. 23 2619-2626
© 2001 Oxford University Press
Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer
Department of Biochemistry and Molecular Biology and 1Department of Urology, USC/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA and 2Vollum Institute and Department of Molecular and Medical Genetics, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97201, USA
The methylation status of binding sites of the insulator protein, CTCF, in the H19 promoter has been suggested as being critical to the regulation of imprinting of the H19/IGF2 locus located in chromosome 11p15. In this study, we have analyzed the methylation of all of seven potential CTCF-binding sites in the human H19 promoter since the methylation status of these sites has not been reported. We found that all the binding sites except the sixth were hypermethylated whereas only the sixth binding site showed allele-specific methylation in normal human embryonic ureteral tissue. We also analyzed the methylation status of these sites in humanmouse somatic-cell-hybrid clones containing a single copy of human chromosome 11 and which were treated with 5-aza-2'-deoxycytidine (5-aza-CdR) to yield clones which expressed human IGF2 and H19 mutually exclusively of each other. In most of the clones, a correlation between methylation of the sixth CTCF-binding site and expression of IGF2 was observed. Therefore, we analyzed the methylation status of this site in human bladder cancer and found hypomethylation of the paternal allele in two of six informative cases. These results demonstrate that only the sixth CTCF-binding site acts as a key regulatory domain for switching between H19 or IGF2 expression, whereas the other sites are not subject to allele-specific methylation. Loss of methylation imprinting of H19 is linked to hypomethylation of the paternal allele in human bladder cancer, unlike the situation in Wilms tumor and colon cancer where the maternal allele becomes hypermethylated.
+ To whom correspondence should be addressed. Tel: +1 323 865 0816; Fax: +1 323 865 0102; Email: jones_p@ccnt.hsc.usc.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Goto and H. Kimura Inactive X chromosome-specific histone H3 modifications and CpG hypomethylation flank a chromatin boundary between an X-inactivated and an escape gene Nucleic Acids Res., October 20, 2009; (2009) gkp860v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, J. Xie, M. Zhang, and S. Wang Homocysteine harasses the imprinting expression of IGF2 and H19 by demethylation of differentially methylated region between IGF2/H19 genes Acta Biochim Biophys Sin, June 1, 2009; 41(6): 464 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nguyen, G. Bar-Sela, L. Sun, K. S. Bisht, H. Cui, E. Kohn, A. P. Feinberg, and D. Gius BAT3 and SET1A Form a Complex with CTCFL/BORIS To Modulate H3K4 Histone Dimethylation and Gene Expression Mol. Cell. Biol., November 1, 2008; 28(21): 6720 - 6729. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nguyen, H. Cui, K. S. Bisht, L. Sun, K. Patel, R. S. Lee, H. Kugoh, M. Oshimura, A. P. Feinberg, and D. Gius CTCFL/BORIS Is a Methylation-Independent DNA-Binding Protein That Preferentially Binds to the Paternal H19 Differentially Methylated Region Cancer Res., July 15, 2008; 68(14): 5546 - 5551. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.J. Marques, P. Costa, B. Vaz, F. Carvalho, S. Fernandes, A. Barros, and M. Sousa Abnormal methylation of imprinted genes in human sperm is associated with oligozoospermia Mol. Hum. Reprod., February 1, 2008; 14(2): 67 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Thurston, J. Taylor, J. Gardner, K. D Sinclair, and L. E Young Monoallelic expression of nine imprinted genes in the sheep embryo occurs after the blastocyst stage Reproduction, January 1, 2008; 135(1): 29 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Byun, H.-L. Wong, E. A. Birnstein, E. M. Wolff, G. Liang, and A. S. Yang Examination of IGF2 and H19 Loss of Imprinting in Bladder Cancer Cancer Res., November 15, 2007; 67(22): 10753 - 10758. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sparago, S. Russo, F. Cerrato, S. Ferraiuolo, P. Castorina, A. Selicorni, C. Schwienbacher, M. Negrini, G. B. Ferrero, M. C. Silengo, et al. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour Hum. Mol. Genet., February 1, 2007; 16(3): 254 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tost, H. Jammes, J.-M. Dupont, C. Buffat, B. Robert, T.-M. Mignot, F. Mondon, B. Carbonne, U. Simeoni, G. Grange, et al. Non-random, individual-specific methylation profiles are present at the sixth CTCF binding site in the human H19/IGF2 imprinting control region Nucleic Acids Res., November 14, 2006; 34(19): 5438 - 5448. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Murphy, Z. Huang, Y. Wen, M. A. Spillman, R. S. Whitaker, L. R. Simel, T. D. Nichols, J. R. Marks, and A. Berchuck Frequent IGF2/H19 Domain Epigenetic Alterations and Elevated IGF2 Expression in Epithelial Ovarian Cancer Mol. Cancer Res., April 1, 2006; 4(4): 283 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Diaz-Meyer, Y Yang, S N Sait, E R Maher, and M J Higgins Alternative mechanisms associated with silencing of CDKN1C in Beckwith-Wiedemann syndrome J. Med. Genet., August 1, 2005; 42(8): 648 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fujimoto, S.M. Mitalipov, L.L. Clepper, and D.P. Wolf Development of a monkey model for the study of primate genomic imprinting Mol. Hum. Reprod., June 1, 2005; 11(6): 413 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. West and P. Fraser Remote control of gene transcription Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R101 - R111. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Prawitt, T. Enklaar, B. Gartner-Rupprecht, C. Spangenberg, M. Oswald, E. Lausch, P. Schmidtke, D. Reutzel, S. Fees, R. Lucito, et al. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor PNAS, March 15, 2005; 102(11): 4085 - 4090. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. X. Fu, S. R. Schwarze, M. L. Kenowski, S. LeBlanc, J. Svaren, and D. F. Jarrard A Loss of Insulin-like Growth Factor-2 Imprinting Is Modulated by CCCTC-binding Factor Down-regulation at Senescence in Human Epithelial Cells J. Biol. Chem., December 10, 2004; 279(50): 52218 - 52226. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lewis, K. Mitsuya, M. Constancia, and W. Reik Tandem Repeat Hypothesis in Imprinting: Deletion of a Conserved Direct Repeat Element Upstream of H19 Has No Effect on Imprinting in the Igf2-H19 Region Mol. Cell. Biol., July 1, 2004; 24(13): 5650 - 5656. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Ulaner, Y. Yang, J.-F. Hu, T. Li, T. H. Vu, and A. R. Hoffman CTCF Binding at the Insulin-Like Growth Factor-II (IGF2)/H19 Imprinting Control Region Is Insufficient to Regulate IGF2/H19 Expression in Human Tissues Endocrinology, October 1, 2003; 144(10): 4420 - 4426. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sandovici, M. Leppert, P. R. Hawk, A. Suarez, Y. Linares, and C. Sapienza Familial aggregation of abnormal methylation of parental alleles at the IGF2/H19 and IGF2R differentially methylated regions Hum. Mol. Genet., July 1, 2003; 12(13): 1569 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Ulaner, T. H. Vu, T. Li, J.-F. Hu, X.-M. Yao, Y. Yang, R. Gorlick, P. Meyers, J. Healey, M. Ladanyi, et al. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site Hum. Mol. Genet., March 1, 2003; 12(5): 535 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cui, P. Onyango, S. Brandenburg, Y. Wu, C.-L. Hsieh, and A. P. Feinberg Loss of Imprinting in Colorectal Cancer Linked to Hypomethylation of H19 and IGF2 Cancer Res., November 15, 2002; 62(22): 6442 - 6446. [Abstract] [Full Text] [PDF] |
||||











